Synvivo

SynVivo develops advanced organ-on-chip platforms that model human vascular and barrier biology under physiologic flow. Its flagship SynBBB™ enables predictive assessment of CNS drug transport, antibody and viral vector delivery, and neuroinflammation using integrated TEER-on-chip sensing. Complementary models such as SynRAM™, SynTumor™, and VascuLink™ extend to immune, oncology, and multi-organ studies—offering scalable, human-relevant alternatives to animal testing.

www.synvivobio.com